CAR T-Cell Therapy for Multiple Myeloma: BCMA Targets, Eligibility, Response and Side Effects

Learn CAR-T Therapy in Multiple Myeloma with a focused overview of multiple myeloma treatment, BCMA CAR T therapy, and proteasome inhibitors. It focuses on immunomodulatory drugs, monoclonal antibodies, and myeloma relapse, with practical context for diagnosis, treatment sequencing, expected outcomes, and follow-up. The video is especially relevant to people searching for multiple myeloma treatment, immunomodulatory drugs, or monoclonal antibodies and wanting a clearer explanation of how oncologists make treatment decisions. Helpful for understanding how specialists personalize cancer care using stage, pathology, biomarkers, and overall health. Treatment plans vary with stage pathology molecular features prior therapy and patient fitness. Ask the